U.S. Markets closed

Why The Biggest IPO In Biotech History Could Have A 'Disruptive' Impact

ALLISON GATLIN
Why The Biggest IPO In Biotech History Could Have A 'Disruptive' Impact

Moderna stock popped Friday after an analyst rated it a buy, saying the biotech could launch a "disruptive class of medicines." Moderna is experimenting with messenger RNA in several areas.